Clinical Trial Update: A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers [Phase 1]

View source ↗

Summary

Pfizer conducted a multiple-dose Phase 1 study of PF-04620110 in overweight and obese, otherwise healthy volunteers; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• PF-04620110

Snippet

Sponsor: Pfizer | Conditions: Obesity, Overweight | Phase 1 | Status: COMPLETED